| Q39043159 | Assessing the bioaccumulation potential of ionizable organic compounds: Current knowledge and research priorities. |
| Q35673015 | BioDMET: a physiologically based pharmacokinetic simulation tool for assessing proposed solutions to complex biological problems. |
| Q39548977 | Characterization of Pharmacokinetics in the Göttingen Minipig with Reference Human Drugs: An In Vitro and In Vivo Approach |
| Q37254283 | Drug absorption modeling as a tool to define the strategy in clinical formulation development |
| Q50568066 | Estimation of acidity constants, ionic mobilities and charges of antimicrobial peptides by capillary electrophoresis. |
| Q39730914 | In vivo-in vitro-in silico pharmacokinetic modelling in drug development: current status and future directions |
| Q31152600 | Metabolic Profiling of Human Long-Term Liver Models and Hepatic Clearance Predictions from In Vitro Data Using Nonlinear Mixed-Effects Modeling |
| Q34537529 | Model-based drug development: the road to quantitative pharmacology |
| Q28088352 | Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification |
| Q37112481 | Physiologically based modeling of lisofylline pharmacokinetics following intravenous administration in mice |
| Q35054518 | Physiologically based pharmacokinetic modeling: methodology, applications, and limitations with a focus on its role in pediatric drug development |
| Q46379587 | Physiologically based pharmacokinetic modelling to predict single- and multiple-dose human pharmacokinetics of bitopertin |
| Q37619315 | Physiologically-based PK/PD modelling of therapeutic macromolecules |
| Q33496817 | Practical anticipation of human efficacious doses and pharmacokinetics using in vitro and preclinical in vivo data |
| Q33516585 | Prediction of pharmacokinetic profile of valsartan in human based on in vitro uptake transport data |
| Q83696544 | Prodrug approaches to improving the oral absorption of antiviral nucleotide analogues |
| Q26764870 | Recent developments in using mechanistic cardiac modelling for drug safety evaluation |
| Q34565898 | Reinforcing effects of methylenedioxy amphetamine congeners in rhesus monkeys: are intravenous self-administration experiments relevant to MDMA neurotoxicity? |
| Q33651477 | Risk Assessment in Extrapolation of Pharmacokinetics from Preclinical Data to Humans |
| Q83763229 | Towards a better prediction of peak concentration, volume of distribution and half-life after oral drug administration in man, using allometry |
| Q34065785 | Translational considerations for cancer nanomedicine |
| Q41958760 | Utility of a single adjusting compartment: a novel methodology for whole body physiologically-based pharmacokinetic modelling |